Disparities in human papillomavirus vaccine completion among vaccine initiators

Betty Chou, Lauren S. Krill, Bernice B. Horton, Christopher E. Barat, Cornelia L Trimble

Research output: Contribution to journalArticle

Abstract

Objective: To estimate rates of completing the full three-dose prophylactic human papillomavirus (HPV) vaccination regimen in patients who initiated the series and to identify variables associated with not completing vaccination. Methods: This single-institution review identified all patients initiating HPV vaccination at one of four affiliated clinics between January 2007 and June 2008. Vaccination "completers" were defined as patients who had completed all three vaccinations within 12 months of initiating the vaccination series. Logistic regression was used to identify factors associated with vaccine completion. Variables analyzed included age, type of insurance (private compared with public), practice location (urban compared with suburban), practice type (pediatrics, gynecology, or family practice), and race or ethnicity (white or African American and Hispanic). Results: Of the 1,413 girls and young women who initiated HPV vaccination, 469 (33.2%) completed the vaccine series. Overall, private insurances (odds ratio 1.87, 95% confidence interval 1.26-2.76) and suburban practice locations (odds ratio 1.44, 95% confidence interval 1.04-1.98) were associated with higher vaccine completion rates. African American race was associated with lower completion rates (odds ratio 0.50, 95% confidence interval 0.38-0.65). In multivariable analyses, the combination of younger age (11-17 years) and urban practice location was associated with very low likelihood of completing HPV vaccination (22%; P=.023). CONCLUSION:: The HPV vaccine completion rate is low. When resources are limited, disparities in HPV vaccine completion should be considered when developing programs to improve vaccine utilization. Urban girls and young women should be targeted as an at-risk population.

Original languageEnglish (US)
Pages (from-to)14-20
Number of pages7
JournalObstetrics and Gynecology
Volume118
Issue number1
DOIs
StatePublished - Jul 2011

Fingerprint

Papillomavirus Vaccines
Vaccination
Vaccines
Odds Ratio
Confidence Intervals
Insurance
African Americans
Family Practice
Gynecology
Hispanic Americans
Logistic Models
Pediatrics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Disparities in human papillomavirus vaccine completion among vaccine initiators. / Chou, Betty; Krill, Lauren S.; Horton, Bernice B.; Barat, Christopher E.; Trimble, Cornelia L.

In: Obstetrics and Gynecology, Vol. 118, No. 1, 07.2011, p. 14-20.

Research output: Contribution to journalArticle

Chou, Betty ; Krill, Lauren S. ; Horton, Bernice B. ; Barat, Christopher E. ; Trimble, Cornelia L. / Disparities in human papillomavirus vaccine completion among vaccine initiators. In: Obstetrics and Gynecology. 2011 ; Vol. 118, No. 1. pp. 14-20.
@article{c65920927ff24cf9a3f028585c067fd8,
title = "Disparities in human papillomavirus vaccine completion among vaccine initiators",
abstract = "Objective: To estimate rates of completing the full three-dose prophylactic human papillomavirus (HPV) vaccination regimen in patients who initiated the series and to identify variables associated with not completing vaccination. Methods: This single-institution review identified all patients initiating HPV vaccination at one of four affiliated clinics between January 2007 and June 2008. Vaccination {"}completers{"} were defined as patients who had completed all three vaccinations within 12 months of initiating the vaccination series. Logistic regression was used to identify factors associated with vaccine completion. Variables analyzed included age, type of insurance (private compared with public), practice location (urban compared with suburban), practice type (pediatrics, gynecology, or family practice), and race or ethnicity (white or African American and Hispanic). Results: Of the 1,413 girls and young women who initiated HPV vaccination, 469 (33.2{\%}) completed the vaccine series. Overall, private insurances (odds ratio 1.87, 95{\%} confidence interval 1.26-2.76) and suburban practice locations (odds ratio 1.44, 95{\%} confidence interval 1.04-1.98) were associated with higher vaccine completion rates. African American race was associated with lower completion rates (odds ratio 0.50, 95{\%} confidence interval 0.38-0.65). In multivariable analyses, the combination of younger age (11-17 years) and urban practice location was associated with very low likelihood of completing HPV vaccination (22{\%}; P=.023). CONCLUSION:: The HPV vaccine completion rate is low. When resources are limited, disparities in HPV vaccine completion should be considered when developing programs to improve vaccine utilization. Urban girls and young women should be targeted as an at-risk population.",
author = "Betty Chou and Krill, {Lauren S.} and Horton, {Bernice B.} and Barat, {Christopher E.} and Trimble, {Cornelia L}",
year = "2011",
month = "7",
doi = "10.1097/AOG.0b013e318220ebf3",
language = "English (US)",
volume = "118",
pages = "14--20",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Disparities in human papillomavirus vaccine completion among vaccine initiators

AU - Chou, Betty

AU - Krill, Lauren S.

AU - Horton, Bernice B.

AU - Barat, Christopher E.

AU - Trimble, Cornelia L

PY - 2011/7

Y1 - 2011/7

N2 - Objective: To estimate rates of completing the full three-dose prophylactic human papillomavirus (HPV) vaccination regimen in patients who initiated the series and to identify variables associated with not completing vaccination. Methods: This single-institution review identified all patients initiating HPV vaccination at one of four affiliated clinics between January 2007 and June 2008. Vaccination "completers" were defined as patients who had completed all three vaccinations within 12 months of initiating the vaccination series. Logistic regression was used to identify factors associated with vaccine completion. Variables analyzed included age, type of insurance (private compared with public), practice location (urban compared with suburban), practice type (pediatrics, gynecology, or family practice), and race or ethnicity (white or African American and Hispanic). Results: Of the 1,413 girls and young women who initiated HPV vaccination, 469 (33.2%) completed the vaccine series. Overall, private insurances (odds ratio 1.87, 95% confidence interval 1.26-2.76) and suburban practice locations (odds ratio 1.44, 95% confidence interval 1.04-1.98) were associated with higher vaccine completion rates. African American race was associated with lower completion rates (odds ratio 0.50, 95% confidence interval 0.38-0.65). In multivariable analyses, the combination of younger age (11-17 years) and urban practice location was associated with very low likelihood of completing HPV vaccination (22%; P=.023). CONCLUSION:: The HPV vaccine completion rate is low. When resources are limited, disparities in HPV vaccine completion should be considered when developing programs to improve vaccine utilization. Urban girls and young women should be targeted as an at-risk population.

AB - Objective: To estimate rates of completing the full three-dose prophylactic human papillomavirus (HPV) vaccination regimen in patients who initiated the series and to identify variables associated with not completing vaccination. Methods: This single-institution review identified all patients initiating HPV vaccination at one of four affiliated clinics between January 2007 and June 2008. Vaccination "completers" were defined as patients who had completed all three vaccinations within 12 months of initiating the vaccination series. Logistic regression was used to identify factors associated with vaccine completion. Variables analyzed included age, type of insurance (private compared with public), practice location (urban compared with suburban), practice type (pediatrics, gynecology, or family practice), and race or ethnicity (white or African American and Hispanic). Results: Of the 1,413 girls and young women who initiated HPV vaccination, 469 (33.2%) completed the vaccine series. Overall, private insurances (odds ratio 1.87, 95% confidence interval 1.26-2.76) and suburban practice locations (odds ratio 1.44, 95% confidence interval 1.04-1.98) were associated with higher vaccine completion rates. African American race was associated with lower completion rates (odds ratio 0.50, 95% confidence interval 0.38-0.65). In multivariable analyses, the combination of younger age (11-17 years) and urban practice location was associated with very low likelihood of completing HPV vaccination (22%; P=.023). CONCLUSION:: The HPV vaccine completion rate is low. When resources are limited, disparities in HPV vaccine completion should be considered when developing programs to improve vaccine utilization. Urban girls and young women should be targeted as an at-risk population.

UR - http://www.scopus.com/inward/record.url?scp=79959679654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959679654&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e318220ebf3

DO - 10.1097/AOG.0b013e318220ebf3

M3 - Article

C2 - 21691158

AN - SCOPUS:79959679654

VL - 118

SP - 14

EP - 20

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 1

ER -